Voya Investment Management LLC Purchases 2,639 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Voya Investment Management LLC raised its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 156,575 shares of the company's stock after buying an additional 2,639 shares during the period. Voya Investment Management LLC owned about 0.52% of Inspire Medical Systems worth $29,026,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Tidal Investments LLC bought a new stake in shares of Inspire Medical Systems during the third quarter valued at approximately $320,000. Synovus Financial Corp grew its position in shares of Inspire Medical Systems by 7.5% in the 3rd quarter. Synovus Financial Corp now owns 3,502 shares of the company's stock worth $739,000 after buying an additional 244 shares during the period. Oddo BHF Asset Management Sas bought a new position in shares of Inspire Medical Systems in the 3rd quarter worth about $1,208,000. Principal Financial Group Inc. increased its stake in shares of Inspire Medical Systems by 3,812.6% in the 3rd quarter. Principal Financial Group Inc. now owns 141,089 shares of the company's stock worth $29,777,000 after acquiring an additional 137,483 shares in the last quarter. Finally, Diversified Trust Co boosted its stake in Inspire Medical Systems by 3.8% during the fourth quarter. Diversified Trust Co now owns 4,686 shares of the company's stock worth $869,000 after acquiring an additional 173 shares in the last quarter. Institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Trading Down 0.1 %

Inspire Medical Systems stock traded down $0.20 during trading on Thursday, reaching $158.18. The company had a trading volume of 279,891 shares, compared to its average volume of 581,606. The firm has a market capitalization of $4.71 billion, a price-to-earnings ratio of 91.43, a price-to-earnings-growth ratio of 2.86 and a beta of 1.39. The firm's 50-day simple moving average is $161.71 and its 200 day simple moving average is $180.41. Inspire Medical Systems, Inc. has a 52 week low of $123.00 and a 52 week high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of Inspire Medical Systems stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now directly owns 10,424 shares of the company's stock, valued at $1,777,187.76. This trade represents a 5.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Randy Ban sold 25,584 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares in the company, valued at approximately $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on INSP shares. Stifel Nicolaus cut their price target on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Morgan Stanley reduced their price objective on shares of Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a research note on Tuesday, February 11th. Piper Sandler reduced their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Truist Financial lowered their price objective on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a research report on Tuesday, February 11th. Finally, Royal Bank of Canada reduced their target price on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $218.90.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.